QHP Capital

Applied StemCell Inc. is a biotechnology company specializing in animal and cell line models that facilitate drug discovery and diagnostics. The company employs its proprietary TARGATT gene modification technology to efficiently create site-specific Knockin mouse, rat, and human cell line models, catering to both pharmaceutical and academic researchers. Applied StemCell focuses on developing and commercializing various models, including Knockin, Knockout, and Transgenic mouse models, humanized mouse models, and gene-modified human cell lines derived from induced pluripotent stem cells. Additionally, the company offers optimized stem cell culture products and gene engineering solutions for mammalian cells. By continuously enhancing its technologies and expanding its product offerings, Applied StemCell aims to support the evolving needs of the biomedical community and advance next-generation biomedical research.

CoPilot Provider Support Services provides innovative, patient-centric hub, and market-access services to manufacturers.

AutoCruitment has created an automated platform designed to enhance the recruitment of patients for clinical trials and research studies. By leveraging advanced algorithms and a streamlined recruitment process, the company addresses the challenges associated with finding qualified volunteers. The platform utilizes over 400 online channels to effectively target and screen potential participants, significantly improving patient acquisition for various clinical trials, including Phase I-IV and medical device studies. This approach not only reduces the cost per subject acquired by 75% compared to traditional advertising methods, but also boosts enrollment numbers and accelerates trial timelines, ultimately transforming the clinical trial recruitment landscape.